These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3277517)

  • 1. Indications for antiarrhythmic therapy: a wealth of controversy, a dearth of data.
    Woosley RL
    Ann Intern Med; 1988 Mar; 108(3):450-2. PubMed ID: 3277517
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring antiarrhythmic drug efficacy by suppression of asymptomatic ventricular arrhythmias.
    Winkle RA
    Ann Intern Med; 1979 Sep; 91(3):480-2. PubMed ID: 475177
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of long-term antiarrhythmic therapy: studies on the long-term efficacy and toxicity of tocainide.
    Engler R; Ryan W; LeWinter M; Bluestein H; Karliner JS
    Am J Cardiol; 1979 Mar; 43(3):612-8. PubMed ID: 420111
    [No Abstract]   [Full Text] [Related]  

  • 4. Sudden cardiac death, ventricular arrhythmias, and antiarrhythmic therapy: current trials and tribulations.
    Anderson JL
    Aust N Z J Med; 1986 Jun; 16(3):409-12. PubMed ID: 3535769
    [No Abstract]   [Full Text] [Related]  

  • 5. New approaches to drug selection and serial drug testing.
    Somberg JC
    J Clin Pharmacol; 1984 Jul; 24(7):320-7. PubMed ID: 6207209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive compounds as antiarrhythmic agents: focus on beta-blocking drugs in ventricular arrhythmias.
    Singh BN; Nademanee K
    Am Heart J; 1987 Oct; 114(4 Pt 2):1040-50. PubMed ID: 2444089
    [No Abstract]   [Full Text] [Related]  

  • 7. Premature ventricular complexes. Diagnosis and indications for therapy.
    Morganroth J
    JAMA; 1984 Aug; 252(5):673-6. PubMed ID: 6737674
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].
    Meinertz T; Zehender M; Hohnloser SH
    Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmias and antiarrhythmic agents.
    Heddle WF; Tonkin AM
    Med J Aust; 1984 Nov; 141(11):715-8. PubMed ID: 6503764
    [No Abstract]   [Full Text] [Related]  

  • 10. Recorded sudden cardiac death: relationship to antiarrhythmic therapy.
    Hohnloser SH; Meinertz T
    Eur Heart J; 1988 Feb; 9 Suppl B():27-31. PubMed ID: 3286264
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug prevention and therapy of ventricular tachycardia].
    Burckhardt D; Hoffmann A
    Ther Umsch; 1992 Aug; 49(8):543-9. PubMed ID: 1519183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac arrhythmia in hypertrophic cardiomyopathy. Diagnosis and therapy].
    Kuck KH
    Internist (Berl); 1987 Mar; 28(3):168-74. PubMed ID: 3294723
    [No Abstract]   [Full Text] [Related]  

  • 13. Principles underlying the use of Holter monitoring to define the efficacy of antiarrhythmic drugs.
    Moss AJ; Zareba W
    Coron Artery Dis; 1994 Aug; 5(8):665-70. PubMed ID: 8000618
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic effects of oral indecainide in patients with ventricular tachyarrhythmias.
    Macina G; Turitto G; Stavens C; Fontaine J; Hariman R; Ursell S; el-Sherif N
    Clin Cardiol; 1987 Jun; 10(6):357-61. PubMed ID: 3594958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmias in patients with CHF. Should they be treated?
    Ellenbogen KA; Martin ML; Sheehan H
    Postgrad Med; 1990 Nov; 88(6):50-6, 61. PubMed ID: 2235787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the treatment of malignant ventricular arrhythmias: new hope for prolonged survival.
    Bissett JK; Sharma B; Franciosa JA
    J Ark Med Soc; 1985 May; 81(12):635-9. PubMed ID: 2975648
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ventricular arrhythmias and sudden death: diagnostic, prognostic and therapeutic aspects].
    Van Durme JP
    Verh K Acad Geneeskd Belg; 1981; 43(3):129-84. PubMed ID: 7336827
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
    Rydén L; Hjalmarson A; Wasir H; Werkö L
    Br Heart J; 1974 Aug; 36(8):811-21. PubMed ID: 4413111
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of cardiac arrhythmias].
    Lewalter T; Lüderitz B
    Internist (Berl); 2000 Apr; 41 Suppl 1():S22-33. PubMed ID: 10840661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Causes and treatment of ventricular arrhythmias].
    Kappenberger L
    Schweiz Med Wochenschr; 1990 Jun; 120(25):941-5. PubMed ID: 1695020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.